CMS Returns To Part D Rule, But Steers Clear of Controversial Policies
This article was originally published in RPM Report
Executive Summary
CMS is getting around to some unfinished business by finalizing some changes to the Medicare Advantage and Part D Drug benefit programs first laid out in a January 2014 draft proposal. The agency, however, is not trying to reopen the controversy that proposed rule set off.